These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 34371769)

  • 21. Choline Kinase Alpha Is a Novel Transcriptional Target of the Brg1 in Hepatocyte: Implication in Liver Regeneration.
    Kong M; Dong W; Xu H; Fan Z; Miao X; Guo Y; Li C; Ye Q; Wang Y; Xu Y
    Front Cell Dev Biol; 2021; 9():705302. PubMed ID: 34422825
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A ROS-responsive polymeric prodrug nanosystem with self-amplified drug release for PSMA (-) prostate cancer specific therapy.
    Wang Y; Zhang Y; Ru Z; Song W; Chen L; Ma H; Sun L
    J Nanobiotechnology; 2019 Aug; 17(1):91. PubMed ID: 31451114
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel β- and γ-Amino Acid-Derived Inhibitors of Prostate-Specific Membrane Antigen.
    Kim K; Kwon H; Barinka C; Motlova L; Nam S; Choi D; Ha H; Nam H; Son SH; Minn I; Pomper MG; Yang X; Kutil Z; Byun Y
    J Med Chem; 2020 Mar; 63(6):3261-3273. PubMed ID: 32097010
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CHKA mediates the poor prognosis of lung adenocarcinoma and acts as a prognostic indicator.
    Zhang L; Chen P; Yang S; Li G; Bao W; Wu P; Jiang S
    Oncol Lett; 2016 Sep; 12(3):1849-1853. PubMed ID: 27588131
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design, synthesis, radiolabeling and biological evaluation of new urea-based peptides targeting prostate specific membrane antigen.
    Mosayebnia M; Hajimahdi Z; Beiki D; Rezaeianpour M; Hajiramezanali M; Geramifar P; Sabzevari O; Amini M; Hatamabadi D; Shahhosseini S
    Bioorg Chem; 2020 Jun; 99():103743. PubMed ID: 32217372
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA-367-3p induces apoptosis and suppresses migration of MCF-7 cells by downregulating the expression of human choline kinase α.
    Raikundalia S; Sa'Dom SAFM; Few LL; Too WCS
    Oncol Lett; 2021 Mar; 21(3):183. PubMed ID: 33574922
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Crosstalk of FGFR1 signaling and choline metabolism promotes cell proliferation and survival in prostate cancer cells.
    Fan Z; Ma J; Pan X; Zhao L; Wu Y; Lin H; Zhao Y; Jiang H; Pan T; Li X; Wang F; Wang C
    Int J Cancer; 2022 May; 150(9):1525-1536. PubMed ID: 34985768
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lys-urea-Aad, Lys-urea-Cmc and Lys-urea-Cms as potential pharmacophores for the design of PSMA-targeted radioligands to reduce off-target uptake in kidneys and salivary glands.
    Kuo HT; Zhang Z; Zhang C; Merkens H; Tan R; Wong AAWL; Uribe CF; Bénard F; Lin KS
    Theranostics; 2023; 13(13):4559-4573. PubMed ID: 37649602
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prostate-Specific Membrane Antigen and Esterase Dual Responsive Camptothecin-Oligopeptide Self-Assembled Nanoparticles for Efficient Anticancer Drug Delivery.
    Xu B; Yan M; Zhou F; Cai D; Guo W; Jia X; Liu R; Ma T; Li T; Gao F; Wang P; Lei H
    Int J Nanomedicine; 2021; 16():7959-7974. PubMed ID: 34887660
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-invasive in vivo imaging of early metabolic tumor response to therapies targeting choline metabolism.
    Mignion L; Danhier P; Magat J; Porporato PE; Masquelier J; Gregoire V; Muccioli GG; Sonveaux P; Gallez B; Jordan BF
    Int J Cancer; 2016 Apr; 138(8):2043-9. PubMed ID: 26595604
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Choline kinase alpha impairment overcomes TRAIL resistance in ovarian cancer cells.
    Rizzo A; Satta A; Garrone G; Cavalleri A; Napoli A; Raspagliesi F; Figini M; De Cecco L; Iorio E; Tomassetti A; Mezzanzanica D; Bagnoli M
    J Exp Clin Cancer Res; 2021 Jan; 40(1):5. PubMed ID: 33390181
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Knockdown of choline kinase α (CHKA) inhibits the proliferation, invasion and migration of human U87MG glioma cells].
    Yue F; Zou Y; Sun S; Wang Z; Huang L; Ma H
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2020 Aug; 36(8):724-728. PubMed ID: 32958130
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polymorphic variants of genes involved in choline pathway and the risk of intrauterine fetal death.
    Drews K; Różycka A; Barlik M; Klejewski A; Kurzawińska G; Wolski H; Majchrzycki M; Gryszczyńska A; Kamiński A; Seremak-Mrozikiewicz A
    Ginekol Pol; 2017; 88(4):205-211. PubMed ID: 28509322
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Global metabolic profile identifies choline kinase alpha as a key regulator of glutathione-dependent antioxidant cell defense in ovarian carcinoma.
    Granata A; Nicoletti R; Perego P; Iorio E; Krishnamachary B; Benigni F; Ricci A; Podo F; Bhujwalla ZM; Canevari S; Bagnoli M; Mezzanzanica D
    Oncotarget; 2015 May; 6(13):11216-30. PubMed ID: 25796169
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural exploration of common pharmacophore based berberine derivatives as novel histone deacetylase inhibitor targeting HDACs enzymes.
    Kandasamy S; Selvaraj M; Muthusamy K; Varadaraju N; Kannupal S; Sekar AK; Vilwanathan R
    J Biomol Struct Dyn; 2023 Mar; 41(5):1690-1703. PubMed ID: 34994284
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative study of cathepsin B-cleavable linkers for the optimal design of cathepsin B-specific doxorubicin prodrug nanoparticles for targeted cancer therapy.
    Shim N; Jeon SI; Yang S; Park JY; Jo M; Kim J; Choi J; Yun WS; Kim J; Lee Y; Shim MK; Kim Y; Kim K
    Biomaterials; 2022 Oct; 289():121806. PubMed ID: 36156411
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overexpression of CHKA contributes to tumor progression and metastasis and predicts poor prognosis in colorectal carcinoma.
    Hu L; Wang RY; Cai J; Feng D; Yang GZ; Xu QG; Zhai YX; Zhang Y; Zhou WP; Cai QP
    Oncotarget; 2016 Oct; 7(41):66660-66678. PubMed ID: 27556502
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and Biological Evaluation of Substrate-Based Imaging Agents for the Prostate-Specific Membrane Antigen.
    Byun Y; Pullambhatla M; Wang H; Mease RC; Pomper MG
    Macromol Res; 2013 May; 21(5):565-573. PubMed ID: 25328507
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanistic insights into mode of action of novel natural cathepsin L inhibitors.
    Tyagi C; Grover S; Dhanjal J; Goyal S; Goyal M; Grover A
    BMC Genomics; 2013; 14 Suppl 8(Suppl 8):S10. PubMed ID: 24564425
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis, Characterization and in vitro Studies of a Cathepsin B-Cleavable Prodrug of the VEGFR Inhibitor Sunitinib.
    Karnthaler-Benbakka C; Koblmüller B; Mathuber M; Holste K; Berger W; Heffeter P; Kowol CR; Keppler BK
    Chem Biodivers; 2019 Jan; 16(1):e1800520. PubMed ID: 30566287
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.